Juno Pharma plans strategic review and explores possible sale
MELBOURNE: Rich List debutant Dennis Bastas, the chairman and major shareholder of Juno Pharmaceuticals, has
MELBOURNE: Rich List debutant Dennis Bastas, the chairman and major shareholder of Juno Pharmaceuticals, has